Development and Application of Treatment for Chikungunya Fever

Area of Science:

• * Medical Entomology
• * Infectious Diseases
• * Public Health

Background:

• * Chikungunya fever (CHIKF), caused by the Chikungunya virus (CHIKV), presents significant global health challenges due to high morbidity and socioeconomic impact.
• * Current treatment lacks standardization, hindering effective patient management and disease control efforts worldwide.
• * Numerous research barriers impede the development and equitable application of effective CHIKF interventions.

Purpose of the Study:

• * To review current and potential treatment strategies for Chikungunya fever.
• * To highlight the challenges and barriers in CHIKF research and treatment development.
• * To emphasize the urgent need for enhanced research to combat the virus.

Main Methods:

• * Literature review of existing research on Chikungunya virus (CHIKV) treatments.
• * Evaluation of natural and pharmaceutical therapeutic approaches for CHIKF symptom management.
• * Analysis of barriers affecting CHIKF research and vaccine development.

Main Results:

• * Natural treatments like homeopathy and physiotherapy offer symptomatic relief for acute and chronic CHIKF.
• * Pharmaceutical options include NSAIDs, methotrexate, chloroquine, and ribavirin, though none are standard treatments.
• * No commercially available vaccine exists, underscoring the need for accelerated vaccine development.

Conclusions:

• * Effective Chikungunya fever treatment requires further research into both natural and pharmaceutical interventions.
• * Overcoming research barriers is crucial for developing efficacious and equitable CHIKF treatments and vaccines.
• * Increased understanding of CHIKV is vital for protecting populations in endemic regions globally.